U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Tobacco Products
  3. Tobacco Science & Research
  4. Research
  5. Treatment for Complex Patients: Continuing and Extended Care (supplement)
  1. Tobacco Science & Research

Treatment for Complex Patients: Continuing and Extended Care (supplement)

Principal Investigator: Joseph Guydish

Funding Mechanism: National Institutes of Health - Grant

ID Number: 3P50DA009253-18S1

Award Date: 9/1/2012

Institution: University of California San Francisco

Tobacco use is highly prevalent among individuals in drug abuse treatment programs. In previous research, the San Francisco Treatment Research Center developed tobacco-related staff and client survey measures and used those measures to study a New York policy to reduce tobacco use in addiction treatment.  In this supplemental study, investigators will survey 552 individuals (252 of whom are smokers) in eight New York drug abuse treatment clinics. Investigators will assess tobacco-related risk perceptions, responses to health warning labels (including graphic warning labels), use of existing and novel tobacco products, receptivity to tobacco marketing/advertising, receptivity to tobacco cessation services, and awareness of FDA regulations. Investigators will also survey treatment program staff members to determine smoking prevalence and responsiveness to health warnings.  Finally, investigators will perform a secondary analysis of New York administrative data to assess factors associated with smoking prevalence in statewide adult drug treatment program admissions from 2006-2012. Findings may inform regulatory activities regarding tobacco use by individuals with mental health and substance abuse diagnoses. (Project completed in 2014.)